Reversibility of pamidronate-associated glomerulosclerosis.

about

Alendronate associated focal segmental glomerulosclerosis: a case report and review of the literature.

P2860

Q38535156-493BEB22-DF62-4626-8282-1DDF96241A78

P2860

Reversibility of pamidronate-associated glomerulosclerosis.

Item

http://www.wikidata.org/entity/Q35868496

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Reversibility of pamidronate-associated glomerulosclerosis.

@ast

Reversibility of pamidronate-associated glomerulosclerosis.

@en

type

Item

label

Reversibility of pamidronate-associated glomerulosclerosis.

@ast

Reversibility of pamidronate-associated glomerulosclerosis.

@en

prefLabel

Reversibility of pamidronate-associated glomerulosclerosis.

@ast

Reversibility of pamidronate-associated glomerulosclerosis.

@en

P1476

Reversibility of pamidronate-associated glomerulosclerosis.

@en

P2093

Andrew Z Fenves

http://www.w3.org/2001/XMLSchema#string

Diana Benavides

http://www.w3.org/2001/XMLSchema#string

Marvin J Stone

http://www.w3.org/2001/XMLSchema#string

Meera Shreedhara

http://www.w3.org/2001/XMLSchema#string

P2860

Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.

Pathologic classification of focal segmental glomerulosclerosis.

Podocyte injury associated glomerulopathies induced by pamidronate.

Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study.

Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.

Nephrotic syndrome after treatment with pamidronate.

Cytochemical and ultrastructural changes in the osteoclast-like giant cells of giant cell tumor of bone following bisphosphonate administration.

Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": a new clinicopathologic entity?

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

P304

249-253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17637879

http://www.w3.org/2001/XMLSchema#string

P932

1906574

http://www.w3.org/2001/XMLSchema#string

Reversibility of pamidronate-associated glomerulosclerosis.

about

P2860

P2860

Reversibility of pamidronate-associated glomerulosclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932